Skip to main
TEM

TEM Stock Forecast & Price Target

TEM Analyst Ratings

Based on 13 analyst ratings
Buy
Strong Buy 46%
Buy 23%
Hold 23%
Sell 8%
Strong Sell 0%

Bulls say

Tempus AI is a strong investment choice as it has shown strong growth and improved cash generation due to a new FDA approved product and expansion plans in the genomics and data segments. With a decrease in interest expenses and a positive cash flow in the future, the company is expected to achieve a CAGR of 25% or higher and has reaffirmed their financial targets. While there may be competition and regulatory concerns, Tempus AI has a diverse portfolio and partnerships with pharmaceutical companies, making it a promising investment option. However, the recent issuance of $400 million in convertible senior notes for debt repayment and general purposes should be monitored.

Bears say

Tempus AI is currently facing challenges with expanding its business due to varying levels of engagement with customers and limited budget allocations for new logo acquisitions, despite its strong presence and partnerships with leading pharmaceutical companies. Additionally, while the company has ambitious goals for growth in its data and diagnostics segments, its recent financial results have seen a widening operating loss. Furthermore, potential volatility in ordering patterns and funding from the US Department of Veteran Affairs for its Million Veteran Program poses a risk to the company's success in the future.

TEM has been analyzed by 13 analysts, with a consensus rating of Buy. 46% of analysts recommend a Strong Buy, 23% recommend Buy, 23% suggest Holding, 8% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Tempus AI Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Tempus AI Inc (TEM) Forecast

Analysts have given TEM a Buy based on their latest research and market trends.

According to 13 analysts, TEM has a Buy consensus rating as of Jul 18, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $68.85, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $68.85, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Tempus AI Inc (TEM)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.